We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£515.00
It has never been this cheap. We have no record of a lower price.
£515 today · cheaper than every other day in the last 3 months
HER-2 Positive Breast Cancer Chemotherapy Outlook India
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 89 days · 89 data points
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 89 days • 1 price levels
Price Analysis
Most common price: £515 (89 days, 100.0%)
Price range: £515 - £515
Price levels: 1 different prices over 89 days
Description
Key Features
Provides latent demand estimates in millions of U.S. dollars for HER-2 positive breast cancer chemotherapy in India.
Includes potential industry earnings (P.I.E.) data across more than 4,900 cities throughout India.
Offers detailed geographic coverage spanning states, union territories, and specific cities.
Reports percent shares for each city relative to its state, union territory, and the total Indian market.
Delivers comparative benchmarks to help evaluate city-level data against regional and national totals.
Supports the development of distribution and sales force strategies through statistical analysis.
Product Specifications
- Format
- paperback
- ASIN
- B0BGKTDW45
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 14 September 2022
- Listed Since
- 28 September 2022
Similar Products You Might Like
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
Price unavailable
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
India Breast Cancer Diagnostic Products Outlook 2023-2028
2023-2028 US Breast Cancer Screening Outlook Study
US Breast Cancer Diagnostic Products Outlook 2023-2028
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
The 2023-2028 Outlook for Breast Cancer Screenings in China
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
World Outlook for Breast Cancer Diagnostic Products 2025-2030
Price unavailable
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
World Outlook for Breast Cancer Screenings 2025-2030
Price unavailable
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies
2023-2028 US Breast Cancer Screening Outlook by Zip Code
India Cancer Supportive Care Drugs Outlook 2023-2028
